Skip to main content

CORRECTION article

Front. Med., 25 October 2024
Sec. Precision Medicine
Volume 11 - 2024 | https://doi.org/10.3389/fmed.2024.1511339

Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience

This article is a correction to:

  1. The molecular tumor board as a step in cancer patient management: a southern Italian experience

    1. Read original article
\r\nStefania Tommasi Stefania Tommasi1*Leonarda MaurmoLeonarda Maurmo1Alessandro RizzoAlessandro Rizzo2Claudia CarellaClaudia Carella2Girolamo RanieriGirolamo Ranieri3Simona De SummaSimona De Summa1Francesco MannavolaFrancesco Mannavola4Vincenzo Emanuele ChiurìVincenzo Emanuele Chiurì5Michele GuidaMichele Guida2Claudia NisiClaudia Nisi6Michele MontroneMichele Montrone2Francesco GiottaFrancesco Giotta2Margherita PatrunoMargherita Patruno7Rosanna LacalamitaRosanna Lacalamita1Brunella PilatoBrunella Pilato1Francesco Alfredo ZitoFrancesco Alfredo Zito8Livia FucciLivia Fucci8Claudio Antonio CoppolaClaudio Antonio Coppola1Paolo DitonnoPaolo Ditonno9Patrizia NardulliPatrizia Nardulli10Davide QuaresminiDavide Quaresmini2Sabino StrippoliSabino Strippoli2
  • 1Unità di Diagnostica Molecolare e Farmacogenetica, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 2Unità Operativa di Oncologia Medica, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 3Unità di Oncologia Interventistica, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 4Unità di Oncologia Medica, Azienda Ospedaliera Policlinico Consorziale di Bari, Bari, Italy
  • 5Unità di Oncologia Medica, Ospedale “Sacro Cuore di Gesù” Gallipoli, Gallipoli, Italy
  • 6Reparto di Oncologia, Ospedale San Giuseppe Moscati Taranto, Taranto, Italy
  • 7Centro Studi Tumori eredo-familiari, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 8Unità Operativa di Anatomia Patologica, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 9Unità Operativa di Ematologia, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy
  • 10Unità Operativa Farmacia e U.M.A.C.A., IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy

A corrigendum on
The molecular tumor board as a step in cancer patient management: a southern Italian experience

by Tommasi, S., Maurmo, L., Rizzo, A., Carella, C., Ranieri, G., De Summa, S., Mannavola, F., Chiurì, V. E., Guida, M., Nisi, C., Montrone, M., Giotta, F., Patruno, M., Lacalamita, R., Pilato, B., Zito, F. A., Fucci, L., Coppola, C. A., Ditonno, P., Nardulli, P., Quaresmini, D., and Strippoli, S. (2024). Front. Med. 11:1432628. doi: 10.3389/fmed.2024.1432628

In the published article, there was an error in the Funding statement. The Ministry of Health funding information is incomplete. It originally stated: “The author(s) that declare financial support was received for the research, authorship, and/or publication of this article. This research has been supported by 5×1000 2021 funds and the Ministry of Health 2023–2024 project funds.” The correct Funding statement appears below.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research has been supported by 5×1000 2021 funds and the Ministry of Health, Ricerca Corrente 2024 deliberation n. 91/2024 funds.

In the published article the following disclaimer was missed:

Author disclaimer

The authors affiliated to the IRCCS Istituto Tumori “Giovanni Paolo II,” Bari are responsible for the views expressed in this article which do not necessarily represent the Institute.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Molecular Tumor Board, precision medicine, comprehensive genomic profile, team, liquid biopsy

Citation: Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, Mannavola F, Chiurì VE, Guida M, Nisi C, Montrone M, Giotta F, Patruno M, Lacalamita R, Pilato B, Zito FA, Fucci L, Coppola CA, Ditonno P, Nardulli P, Quaresmini D and Strippoli S (2024) Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience. Front. Med. 11:1511339. doi: 10.3389/fmed.2024.1511339

Received: 14 October 2024; Accepted: 16 October 2024;
Published: 25 October 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Tommasi, Maurmo, Rizzo, Carella, Ranieri, De Summa, Mannavola, Chiurì, Guida, Nisi, Montrone, Giotta, Patruno, Lacalamita, Pilato, Zito, Fucci, Coppola, Ditonno, Nardulli, Quaresmini and Strippoli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Stefania Tommasi, s.tommasi@oncologico.bari.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.